Intellia Therapeutics, Inc. (NTLA)
12.73
-0.14
(-1.09%)
USD |
NASDAQ |
Aug 31, 16:00
12.67
-0.06
(-0.47%)
After-Hours: 04:57
Intellia Therapeutics Cash from Operations (TTM) : -346.64M for June 30, 2026
Cash from Operations (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -346.64M |
| March 31, 2026 | -363.15M |
| December 31, 2025 | -394.74M |
| September 30, 2025 | -410.65M |
| June 30, 2025 | -418.58M |
| March 31, 2025 | -377.15M |
| December 31, 2024 | -348.88M |
| September 30, 2024 | -356.74M |
| June 30, 2024 | -373.28M |
| March 31, 2024 | -405.42M |
| December 31, 2023 | -394.09M |
| September 30, 2023 | -390.90M |
| June 30, 2023 | -368.05M |
| March 31, 2023 | -362.81M |
| December 31, 2022 | -333.29M |
| September 30, 2022 | -298.07M |
| June 30, 2022 | -284.56M |
| March 31, 2022 | -252.46M |
| December 31, 2021 | -225.03M |
| September 30, 2021 | -210.60M |
| Date | Value |
|---|---|
| June 30, 2021 | -174.14M |
| March 31, 2021 | -63.74M |
| December 31, 2020 | -49.91M |
| September 30, 2020 | -38.35M |
| June 30, 2020 | -35.24M |
| March 31, 2020 | -120.33M |
| December 31, 2019 | -103.24M |
| September 30, 2019 | -83.12M |
| June 30, 2019 | -70.12M |
| March 31, 2019 | -64.94M |
| December 31, 2018 | -61.26M |
| September 30, 2018 | -74.02M |
| June 30, 2018 | -78.46M |
| March 31, 2018 | -71.65M |
| December 31, 2017 | -65.28M |
| September 30, 2017 | -58.38M |
| June 30, 2017 | -49.10M |
| March 31, 2017 | 34.13M |
| December 31, 2016 | 36.11M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (TTM) Benchmarks
| Beam Therapeutics, Inc. | -359.38M |
| Twist Bioscience Corp. | -53.07M |
| Tenaya Therapeutics, Inc. | -52.32M |
| Moderna, Inc. | -1.073B |
| Revolution Medicines, Inc. | -1.223B |